Announcement ·
Anthropic and OpenAI speed up their race for scientific "workbenches"
Original title, in French: “Anthropic et OpenAI accélèrent leur course aux « workbenches » scientifiques”
- Publication
- Silicon.fr (France)
- Author
- Philippe Leroy
- Published on
- 18 September 2026 · read in the page structured data · updated on 18 September 2026
Summary
Danish pharmaceutical company Novo Nordisk has signed an agreement with Anthropic to test Claude Science, a scientific working environment connected to more than sixty databases, having already formed partnerships with OpenAI and Amazon Web Services. According to CEO Mike Doustdar, these tools open up new scientific opportunities. Anthropic is also working with Bristol Myers Squibb, while OpenAI has launched GPT-Rosalind, a model specialised in life sciences, with Amgen, Moderna, the Allen Institute and Thermo Fisher Scientific as pilot partners. The article details the two companies' differing strategies, a generalist approach for Anthropic and verticalisation for OpenAI, and highlights the data governance issues raised by Novo Nordisk.
Summary based on the full text of the article.
Read the article on Silicon.fr →Classification
- Country
- Denmark, United States
- Company size
- Large companies
- Industries
- Healthcare, pharmaceuticals, social care
- Companies
- Amgen (deploys AI), Novartis (cited), Johnson & Johnson (cited), Eli Lilly (cited), UCSF Brain Tumor Center (deploys AI), Merck (cited), Amazon Web Services (supplier), Bristol Myers Squibb (deploys AI), Allen Institute (deploys AI), Google Cloud (supplier), Thermo Fisher Scientific (deploys AI), Novo Nordisk (deploys AI), Microsoft (supplier), OpenAI (supplier), Anthropic (supplier), Moderna (deploys AI), Nvidia (cited)
- Keywords
- generative ai, pharmaceutical research, claude science, gpt-rosalind, r&d, biotechnology
Entry written by Marsanne Studio from the cited article, with the help of an AI model (claude-sonnet-5). The rights to the article and its illustrations belong to Silicon.fr and its author. Entry translated from French by Claude Sonnet 5.5.